Grayscale Sees Huge Bitcoin ETF Outflow, But Record Inflow for VanEck
The world’s largest crypto asset manager is still hemorrhaging Bitcoin with the largest outflow recorded this month, however other funds are inflowing more.
Funds have been flowing out of the Grayscale Bitcoin Trust (GBTC) for more than two months. Moreover, March 11 was the largest outflow for the month.
A whopping $494 million worth of BTC exited the fund yesterday. This works out at 6,850 BTC, according to BitMEX Research, which labeled it a record outflow.
The BitMEX declaration is misleading, however, as GBTC outflows exceeded $500 million for five days in January and again on Feb. 29.
SIX THOUSAND EIGHT HUNDRED AND FIFTY ALL TIME RECORD HIGH BITCOIN WITHDRAWN FROM GBTC TODAY https://t.co/x6j7bQWqbv
— BitMEX Research (@BitMEXResearch) March 11, 2024
BitMEX clarified stating that it meant a record-high in terms of Bitcoin price, before adding it was the sixth-largest outflow in US dollar terms for GBTC.
Why Is BTC Leaving Grayscale?
Grayscale’s Bitcoin holdings have declined by 36% since GBTC was converted into a spot ETF in January. Before the conversion, it held around 620,000 BTC, but that figure has now fallen to 395,744, according to its website. Nevertheless, the remaining assets are still worth $28.5 billion at current BTC prices.
When Grayscale converted the product to a spot ETF, it allowed investors to redeem their shares for the underlying asset for the first time. Moreover, it also has higher fees than competing products from BlackRock and Fidelity, so investors have been cashing out or rebalancing their portfolios.
Regardless of these huge outflows, there have only been two days since the beginning of February when the net flow to all ETFs has been negative.
BlackRock and Fidelity have been hoovering up more BTC than Grayscale, which has been hemorrhaging.
According to preliminary data from Farside Investors, March 11 saw a record inflow for VanEck’s spot Bitcoin ETF, HODL. The fund had $119 million in inflows for the day. This came after an announcement by the company that it would be slashing the fees temporarily.
Fidelity’s FBTC fund saw inflows of $215 million, while Bitwise’s BITB had a $50 million inflow.
Crypto Markets Close on ATH
Crypto market capitalization has reached $2.85 trillion, which is just 8% away from its all-time high. The massive 5.2% gain was driven by Bitcoin yet again as the asset powered to a new peak price of $72,700 in late trading on March 11.
Some of the altcoins are also making big gains, with Ethereum reaching $4,000 and Solana topping $150.
Ripple’s XRP has powered over $0.70 in a 15% gain while Avalanche has surged 19% to reach $50.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
